MICHELLE FUSSNECKER: Open Payments
NPI 1871047753 · BROOMFIELD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,071 in 207 payments from 41 companies in 2025. Trend: 2023 $2,743 · 2024 $3,712 · 2025 $4,071
Food & beverage: $4,071
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 50 | $601 |
| ABBVIE INC. | 26 | $491 |
| Lilly USA, LLC | 12 | $327 |
| TG Therapeutics, Inc. | 12 | $323 |
| EMD Serono, Inc. | 11 | $254 |
| Biogen, Inc. | 13 | $191 |
| ARGENX US, INC. | 6 | $140 |
| UCB, Inc. | 6 | $137 |
| GENZYME CORPORATION | 3 | $133 |
| Alnylam Pharmaceuticals Inc. | 4 | $121 |
Products named: BRIUMVI, NURTEC ODT, QULIPTA, PANZYGA, BOTOX, KISUNLA, VYVGART HYTRULO, AMYVID.
Industry payments across CO — which companies pay providers there.
